Lydia Visser

Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.

Sibrand Poppema, Harry Hollema, Lydia Visser et al. · PubMed · 1987 · 234 citations

Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients

Monique A.J. van Eijndhoven, Josée M. Zijlstra, Nils J. Groenewegen et al. · JCI Insight · 2016 · 171 citations · Full text

Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups

Kevin Y. Urayama, Ruth F. Jarrett, Henrik Hjalgrim et al. · JNCI Journal of the National Cancer Institute · 2012 · 167 citations · Full text

Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.

Wim Timens, Lydia Visser, Sibrand Poppema · PubMed · 1986 · 167 citations

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

Marijke Niens, Ruth F. Jarrett, Bouke G. Hepkema et al. · Blood · 2007 · 152 citations